Global Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the Global Cell and Gene Therapy Manufacturing QC Market was valued at USD 2235.72 Million in 2024 and is projected to reach USD 5458.28 Million by 2028, expanding at a CAGR of 25.1% during the forecast period. This sharp rise is likely due to the growing use of these therapies in the medical and pharmaceutical sectors to cure genetic diseases and cancers. Advancements in gene-editing technologies like CRISPR, pave the way for more efficient and reliable testing procedures, fueling the market growth. The move towards green production and sustainability, with emphasis on low-carbon manufacturing, offers additional market opportunities. Export potential is steadily increasing with the globalization of health services and therapies. As advancements continue, regions are positioning themselves accordingly, for example, the Asia-Pacific region is expected to witness substantial growth due to increased investment in biomedical research.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market Highlights
- By segment, Cell Therapy emerged as the largest Therapy Type in terms of market size in 2024.
- Gene Therapy is anticipated to remain the most attractive Therapy Type segment, recording the fastest growth during the forecast period.
- As of 2024, Global held % of the global cell and gene therapy manufacturing qc market size.
- By 2028, United States is anticipated to capture the largest share of the global cell and gene therapy manufacturing qc market.
- In Global, North America is expected to lead the regional cell and gene therapy manufacturing qc market size by 2028.
- Asia Pacific will remain the fastest-growing market in Global, reaching USD 215275.32 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope |
Details |
| Base Year for Study |
2024 |
| Study Period |
2021-2028 |
| Historical Period |
2021-2023 |
| Forecast Period |
2025-2028 |
| Market Size In 2024 |
USD 2235.72 Million |
| Market Size In 2028 |
USD 5458.28 Million |
| Largest segment |
Cell Therapy |
| Fastest segment |
Gene Therapy |
| Units |
Revenue in USD Million |
| CAGR |
25.1% (2025-2028) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Global Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments |
Sub Segments |
| Region |
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East And Africa
|
| Therapy Type |
- Cell Therapy
- Gene Therapy
|
| Cell Therapy |
- CAR-T
- CAR-NK
- B-Cell
- Other
|
| CAR-T |
- Autologous CAR-T
- Allogeneic CAR-T
|
| Gene Therapy |
- Viral
- Non-Viral
|
| Viral |
- AAV
- Lentiviral vectors
- Other
|
| Scale |
- Pre commercial/ R&D Manufacturing
- Commercial Scale Manufacturing
|
| Mode |
- Contract Manufacturing
- In-house Manufacturing
|
| Workflow |
- Cell Processing
- Cell Banking
- Fill & Finish Operations
- Raw Material Testing
- Vector Production
- Other Workflows
|
| Process |
- Upstream Processes
- Downstream Processes
|
| End User |
- Pharmaceutical Companies
- Biopharmaceutical / Biotechnological Companies
- Contract Manufacturing Organizations
|
| Pharmaceutical Companies |
- Small Size
- Medium Size
- Large Size
|
| Biopharmaceutical / Biotechnological Companies |
- Small Size
- Medium Size
- Large Size
|
| Contract Manufacturing Organizations |
- Small Size
- Medium Size
- Large Size
|
| Technology Type |
- Fluorescence-Activated Cell Sorting (FACS)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chromatography
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- OthersÂ
|
Global Cell and Gene Therapy Manufacturing QC Market By Region 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
Global Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.